XTX Topco’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,357
| Closed | -$392K | – | 2355 |
|
|
2025
Q1 | $392K | Sell |
3,357
-9,794
| -74% | -$1.14M | 0.02% | 1211 |
|
|
2024
Q4 | $1.11M | Buy |
+13,151
| New | +$1.11M | 0.09% | 234 |
|
|
2024
Q3 | – | Sell |
-11,205
| Closed | -$902K | – | 2078 |
|
|
2024
Q2 | $902K | Buy |
11,205
+7,173
| +178% | +$577K | 0.08% | 396 |
|
|
2024
Q1 | $322K | Buy |
+4,032
| New | +$322K | 0.04% | 793 |
|
|
2023
Q4 | – | Sell |
-4,388
| Closed | -$307K | – | 1588 |
|
|
2023
Q3 | $307K | Buy |
4,388
+1,520
| +53% | +$106K | 0.05% | 716 |
|
|
2023
Q2 | $206K | Buy |
+2,868
| New | +$206K | 0.04% | 981 |
|
|
2022
Q4 | – | Sell |
-6,812
| Closed | -$304K | – | 1120 |
|
|
2022
Q3 | $304K | Buy |
+6,812
| New | +$304K | 0.08% | 490 |
|
|
2021
Q2 | – | Sell |
-4,680
| Closed | -$265K | – | 806 |
|
|
2021
Q1 | $265K | Buy |
+4,680
| New | +$265K | 0.13% | 341 |
|